1. Protalix BioTherapeutics, Inc.

    0 Comments Leave a Comment

    1-2 of 2

    1. Mentioned In 2 Articles

    3. Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors

      Explore PR Newswire BoardMoves
      Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors
      CARMIEL,Israel,Dec. 19, 2019/PRNewswire/ -- Protalix BioTherapeutics, Inc.(NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellExplant cell-based protein expression system, today announced the appointment of Pol F. Boudes, MD, andGwen A. Melincoffto its Board of Directors...
      Read Full Article
      Mentions: NYSE Israel Protalix BioTherapeutics, Inc.
    4. 1-2 of 2
  1. Search:

  2. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content

  3. Related Topics

    1. Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors
      2 articles also mentioned Board of Directors
    2. Protalix BioTherapeutics Appoints Shmuel "Muli" Ben Zvi, Ph.D. to its Board of Directors
      1 articles also mentioned Shmuel "Muli" Ben Zvi